BFSG LLC’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$393K Sell
29,058
-3,910
-12% -$46.8K 0.03% 215
2026
Q1
$197K Buy
32,968
+580
+2% +$4.36K 0.02% 276
2025
Q4
$232K Buy
32,388
+9,508
+42% +$75.1K 0.02% 251
2025
Q3
$244K Sell
22,880
-730
-3% -$7.16K 0.02% 249
2025
Q2
$229K Buy
23,610
+7,310
+45% +$75.4K 0.03% 234
2025
Q1
$243K Sell
16,300
-680
-4% -$10.5K 0.03% 222
2024
Q4
$253K Buy
16,980
+2,060
+14% +$33.6K 0.03% 212
2024
Q3
$285K Buy
14,920
+140
+0.9% +$2.9K 0.03% 209
2024
Q2
$306K Sell
14,780
-3,676
-20% -$73.1K 0.04% 199
2024
Q1
$347K Hold
18,456
0.05% 185
2023
Q4
$266K Buy
18,456
+8,091
+78% +$110K 0.04% 207
2023
Q3
$180K Buy
+10,365
New +$216K 0.03% 227

Other funds holding OGN

BFSG LLC's OGN Position: Q2 2026 in Review

BFSG LLC reduced its Organon & Co (OGN) stake by 12% in Q2 2026, selling an estimated $46.8K and leaving 29,058 shares worth $393K. The position accounts for 0.03% of the portfolio, ranked #215.

BFSG LLC first reported a position in OGN in Q3 2023 and has held it in 12 quarters since. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • BFSG LLC held 29,058 shares of Organon & Co worth $393K as of Q2 2026.
  • BFSG LLC sold 3,910 Organon & Co shares in Q2 2026, an estimated $46.8K.
  • Organon & Co made up 0.03% of BFSG LLC's portfolio in Q2 2026, its #215 holding.
  • BFSG LLC first reported a position in Organon & Co in Q3 2023 and has held it in 12 quarters since.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.